The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Ralf René Reinert

Institute for Medical Microbiology

National Reference Centre for Streptococci




Name/email consistency: high



  • Institute for Medical Microbiology, National Reference Centre for Streptococci, Aachen, Germany. 1997 - 2007


  1. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. Reinert, R.R., Low, D.E., Rossi, F., Zhang, X., Wattal, C., Dowzicky, M.J. J. Antimicrob. Chemother. (2007) [Pubmed]
  2. Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Reinert, R.R., van der Linden, M., Seegmüller, I., Al-Lahham, A., Siedler, A., Weissmann, B., Toschke, A.M., von Kries, R. Clin. Microbiol. Infect. (2007) [Pubmed]
  3. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. Reinert, R.R., Ringelstein, A., van der Linden, M., Cil, M.Y., Al-Lahham, A., Schmitz, F.J. J. Clin. Microbiol. (2005) [Pubmed]
  4. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Reinert, R.R., Reinert, S., van der Linden, M., Cil, M.Y., Al-Lahham, A., Appelbaum, P. Antimicrob. Agents Chemother. (2005) [Pubmed]
  5. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22. Reinert, R.R., Al-Lahham, A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  6. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany. Reinert, R.R., van der Linden, M., Al-Lahham, A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  7. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003. Reinert, R.R., Haupts, S., van der Linden, M., Heeg, C., Cil, M.Y., Al-Lahham, A., Fedson, D.S. Clin. Microbiol. Infect. (2005) [Pubmed]
  8. Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones. Reinert, R.R., Jacobs, M.R., Appelbaum, P.C., Bajaksouzian, S., Cordeiro, S., van der Linden, M., Al-Lahham, A. J. Clin. Microbiol. (2005) [Pubmed]
  9. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Reinert, R.R., Lütticken, R., Sutcliffe, J.A., Tait-Kamradt, A., Cil, M.Y., Schorn, H.M., Bryskier, A., Al-Lahham, A. Antimicrob. Agents Chemother. (2004) [Pubmed]
  10. Clinical efficacy of ketolides in the treatment of respiratory tract infections. Reinert, R.R. J. Antimicrob. Chemother. (2004) [Pubmed]
  11. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany. Reinert, R.R., Lütticken, R., Al-Lahham, A. Clin. Microbiol. Infect. (2004) [Pubmed]
  12. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Reinert, R.R., Franken, C., van der Linden, M., Lütticken, R., Cil, M., Al-Lahham, A. Int. J. Antimicrob. Agents (2004) [Pubmed]
  13. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000). Reinert, R.R., Rodloff, A.C., Halle, E., Baer, W., Beyreiss, B., Seifert, H., Wichelhaus, T.A., Maass, M., Mehl, M. Chemotherapy (2004) [Pubmed]
  14. Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000. Reinert, R.R., Lütticken, R., Reinert, S., Al-Lahham, A., Lemmen, S. Chemotherapy (2004) [Pubmed]
  15. Pneumococcal conjugate vaccines--a European perspective. Reinert, R.R. Int. J. Med. Microbiol. (2004) [Pubmed]
  16. Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-20021). Reinert, R.R. J. Chemother (2004) [Pubmed]
  17. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Reinert, R.R., Lütticken, R., Bryskier, A., Al-Lahham, A. Antimicrob. Agents Chemother. (2003) [Pubmed]
  18. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Reinert, R.R., Wild, A., Appelbaum, P., Lütticken, R., Cil, M.Y., Al-Lahham, A. Antimicrob. Agents Chemother. (2003) [Pubmed]
  19. Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing. Reinert, R.R., Muckel, S., Al-Lahham, A., Spratt, B.G., Brueggemann, A.B., Hakenbeck, R., Lütticken, R. J. Med. Microbiol. (2003) [Pubmed]
  20. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. Reinert, R.R., Al-Lahham, A., Lemperle, M., Tenholte, C., Briefs, C., Haupts, S., Gerards, H.H., Lütticken, R. J. Antimicrob. Chemother. (2002) [Pubmed]
  21. Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones. Reinert, R.R., Al-Lahham, A., Lütticken, R., Boos, M., Schmitz, F.J. J. Antimicrob. Chemother. (2002) [Pubmed]
  22. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. Reinert, R.R., Simic, S., Al-Lahham, A., Reinert, S., Lemperle, M., Lütticken, R. J. Clin. Microbiol. (2001) [Pubmed]
  23. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials. Reinert, R.R., von Eiff, C., Kresken, M., Brauers, J., Hafner, D., Al-Lahham, A., Schorn, H., Lütticken, R., Peters, G. J. Clin. Microbiol. (2001) [Pubmed]
  24. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. Reinert, R.R., Al-Lahham, A., Lütticken, R. J. Antimicrob. Chemother. (2001) [Pubmed]
  25. Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany. Reinert, R.R., Conrads, G., Schlaeger, J.J., Werner, G., Witte, W., Lütticken, R., Klare, I. J. Clin. Microbiol. (1999) [Pubmed]
  26. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae. Reinert, R.R., Schlaeger, J.J., Lütticken, R. J. Antimicrob. Chemother. (1998) [Pubmed]
  27. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Reinert, R.R., Bryskier, A., Lütticken, R. Antimicrob. Agents Chemother. (1998) [Pubmed]
  28. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae. Reinert, R.R., Kresken, M., Mechery, V., Lemperle, M., Lütticken, R. Eur. J. Clin. Microbiol. Infect. Dis. (1998) [Pubmed]
  29. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Reinert, R.R., Kaufhold, A., Schlaeger, J.J., Mechery, V., Lütticken, R. Pediatr. Infect. Dis. J. (1997) [Pubmed]
WikiGenes - Universities